Affluent Medical SAS
PAR:AFME
Cash Flow Statement
Cash Flow Statement
Affluent Medical SAS
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(15)
|
(15)
|
(15)
|
(15)
|
(16)
|
(17)
|
(15)
|
(15)
|
|
| Depreciation & Amortization |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
1
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(1)
|
(3)
|
1
|
(1)
|
0
|
6
|
0
|
(2)
|
|
| Cash from Operating Activities |
(12)
N/A
|
(14)
-10%
|
(11)
+18%
|
(13)
-19%
|
(12)
+8%
|
(7)
+41%
|
(11)
-58%
|
(14)
-27%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
5
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+98%
|
(0)
-3 550%
|
(0)
+22%
|
(0)
-61%
|
(0)
-16%
|
(0)
-124%
|
5
N/A
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
21
|
(0)
|
6
|
19
|
13
|
3
|
13
|
9
|
|
| Net Issuance of Debt |
(5)
|
(6)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
4
|
|
| Other |
2
|
3
|
(1)
|
(0)
|
0
|
(0)
|
(0)
|
1
|
|
| Cash from Financing Activities |
18
N/A
|
(3)
N/A
|
2
N/A
|
17
+604%
|
11
-33%
|
1
-91%
|
11
+1 011%
|
14
+23%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
6
N/A
|
(17)
N/A
|
(9)
+47%
|
4
N/A
|
(1)
N/A
|
(6)
-590%
|
(0)
+93%
|
4
N/A
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(13)
N/A
|
(14)
-8%
|
(11)
+18%
|
(13)
-18%
|
(12)
+8%
|
(7)
+40%
|
(11)
-55%
|
(15)
-27%
|
|